IP Library Granted Patent US 9,956,373
Granted Patent B2
US 9,956,373 · App. 14/474,252 · Granted May 1, 2018

Conversion of nitrogen dioxide (NO

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,956,373
App. No.
14/474,252
Granted
May 1, 2018
Kind
B2
Abstract

A nitric oxide delivery system, which includes a gas bottle having nitrogen dioxide in air, converts nitrogen dioxide to nitric oxide and employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid. A nitric oxide delivery system may be used to generate therapeutic gas including nitric oxide for use in delivering the therapeutic gas to a mammal.

Claims (10)

1. A method of delivering nitric oxide comprising:

releasing nitrogen dioxide from a reservoir through a restrictor tube into a delivery conduit, wherein the reservoir includes a nitrogen dioxide source and the restrictor;

passing a gas from a gas supply into the delivery conduit which allows the gas from the gas supply and the nitrogen dioxide to mix in the delivery conduit;

passing the gas and nitrogen dioxide mixture through at least one cartridge, wherein the cartridge comprises a surface-active and a reducing agent; and

delivering nitric oxide from an outlet of the delivery conduit.

2. The method of claim 1 , wherein releasing nitrogen dioxide from a reservoir into a delivery conduit occurs via a restrictor.

3. The method of claim 2 , wherein the restrictor includes a first end and a second end, wherein the first end of the restrictor is coupled to the reservoir and wherein the second end of the restrictor is coupled to the delivery conduit.

4. The method of claim 1 , wherein the tube is a narrow bore needle.

5. The method of claim 1 , wherein the restrictor includes a first end and a second end, and the first end of the restrictor is coupled to the reservoir.

6. The method of claim 5 , wherein the second end of the restrictor is sealed or closed.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Mar 18, 2026
From: HORIZON TECHNOLOGY FINANCE CORPORATION
To: VERO BIOTECH INC.
Reel/Frame 075308/0198 →
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 3, 2024
From: RUNWAY GROWTH FINANCE CORP (F/K/A RUNWAY GROWTH CREDIT FUND INC.)
To: VERO BIOTECH INC. (F/K/A VERO BIOTECH LLC)
Reel/Frame 066186/0611 →
SECURITY INTEREST Recorded Jan 3, 2024
From: VERO BIOTECH INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 066187/0865 →
CHANGE OF NAME Recorded Feb 14, 2022
From: VERO BIOTECH LLC
To: VERO BIOTECH INC.
Reel/Frame 059085/0418 →
SECURITY INTEREST Recorded Dec 29, 2020
From: VERO BIOTECH LLC
To: RUNWAY GROWTH CREDIT FUND INC.
Reel/Frame 054866/0589 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2018
From: ROUNDBEHLER, DAVID R.; FINE, DAVID H.
To: VERO BIOTECH LLC
Reel/Frame 047747/0714 →
CHANGE OF NAME Recorded Jun 6, 2018
From: GENO LLC
To: VERO BIOTECH LLC
Reel/Frame 046310/0135 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2015
From: ROUNDBEHLER, DAVID R.; FINE, DAVID H.
To: GENO LLC
Reel/Frame 035404/0075 →